Carcia Carson, Phd
@CarciaCarson
Followers
208
Following
301
Media
1
Statuses
128
RT @Annals_Oncology: 📢#ASCO25 concomitant publication: Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic ur….
0
8
0
RT @DrKarineTawagi: cTDNA in #NIAGARA by @tompowles1 . 🌀57% (+) at baseline. Prognostic before and after cystectomy:.🌀Clearance 13% higher….
0
10
0
"A stylish woman in a beige coat walking confidently past a moving train at a modern train station.". Create images and videos in seconds with Grok Imagine.
802
719
4K
RT @brian_rini: #ASCO25 Final results of IO-based combinations in mRCC are in! See below and subsequent posts for thoughts. Video discussin….
0
123
0
RT @NateraGenetics: Learn more about Signatera and the foundational technology that is transforming care for patients with cancer. Hear dir….
0
8
0
RT @NateraGenetics: 👋Hello from ASCO 2025! Stop by our booth #13080 to learn more about our latest data. Be sure to catch our 30+ abstracts….
0
2
0
RT @NateraGenetics: Attending #ASCO25? Stop by booth #13080 to learn more about our expanding body of data in solid tumor malignancies and….
0
3
0
RT @NateraOncology: Upcoming presentations from #Natera and collaborators at #ESMO24 include abstracts from the GALAXY arm of the CIRCULATE….
0
2
0
RT @NateraOncology: @myESMO 👋 #ESMO24 Stop by #Natera's booth 311 to meet our team and learn how we use tumor-informed ctDNA analysis to ad….
0
3
0
RT @NateraOncology: [WEBINAR] Join us for our upcoming webinar: Latest data on #ctDNA as a patient selection and early efficacy marker for….
0
1
0
RT @tompowles1: With @MattGalsky #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT & 0.56 in PD-L1 +ve. Clinically meaningful results….
0
70
0
RT @tompowles1: Serial ctDNA testing from IMVIGOR11 (post cystectomy in muscle invasive bladder cancer) show that ctDNA-ve patients (n=17….
0
101
0
RT @BlkBoiScientist: Now this deserves a retweet! Stay Tuned for many more announcements 😊😉.
0
1
0
RT @6Gems: These Suberbowl commercials are leaning heavily on celeb cameos and light on creativity. #SuperBowl2024.
0
24
0
RT @DrRanaMcKay: Evaluation of ctDNA for MRD post nephrectomy. 85% with positive ctDNA had radiographic relapse. ctDNA+ associated with wor….
0
5
0
RT @NateraOncology: “I-SPY2 provides compelling evidence to support the role of #ctDNA in predicting the likelihood of benefit from neoadju….
natera.com
Study with 283 patients, >1,000 plasma samples, and longest follow-up exceeding 5 years demonstrates how ctDNA monitoring can help inform treatment decisions in HR+/HER2- and TNBC patients
0
3
0
RT @POTUS: On Transgender Day of Visibility, we want you to know that we see you just as you are:. Made in the image of God and deserving o….
0
12K
0
RT @NateraOncology: Our team looks forward to seeing everyone at #SSO2023 this week! Mark your calendar for these #Natera presentations on….
0
2
0